Demolombe S, Baró I, Péréon Y, Bliek J, Mohammad-Panah R, Pollard H, Morid S, Mannens M, Wilde A, Barhanin J, Charpentier F, Escande D
Laboratoire de Physiopathologie et de Pharmacologie Cellulaires et Mol-eculaires, INSERM CJF96-01, H-opital H-otel-Dieu, Nantes, France.
J Biol Chem. 1998 Mar 20;273(12):6837-43. doi: 10.1074/jbc.273.12.6837.
Mutations in the KvLQT1 gene are the cause of the long QT syndrome 1. KvLQT1 gene product is associated with the regulator protein IsK to produce a component of the delayed rectifier K+ current in cardiac myocytes. We identified an N-terminal truncated isoform of the KvLQT1 gene product, referred to as isoform 2. In RNase protection assays, isoform 2 represented 28.1 +/- 0.6% of the total KvLQT1 expression in the human adult ventricle. COS-7 cells injected intranuclearly with KvLQT1 isoform 1 cDNA exhibited a fast-activating K+ current, whereas those injected with a KvLQT1 isoform 1 plus IsK cDNA showed a slow-activating K+ current. Cells injected with KvLQT1 isoform 2 plasmid showed no detectable K+ current. Those injected with a 1/1 isoform 2/isoform 1 ratio showed no detectable K+ current. Those injected with 1/5 and 2/5 ratios showed a K+ current with markedly reduced amplitude. Coexpression of the IsK regulator consistently reduced the dominant negative effects of isoform 2. Our results indicate that KvLQT1 isoform 2 exerts a pronounced negative dominance on isoform 1 channels and that the cardiac KvLQT1 K+ channel complex is composed of at least three different proteins as follows: isoform 1, isoform 2, and IsK.
KvLQT1基因突变是长QT综合征1的病因。KvLQT1基因产物与调节蛋白IsK相关联,以产生心肌细胞中延迟整流钾电流的一个成分。我们鉴定出了KvLQT1基因产物的一种N端截短的异构体,称为异构体2。在核糖核酸酶保护分析中,异构体2占成人心室中KvLQT1总表达量的28.1±0.6%。核内注射KvLQT1异构体1 cDNA的COS-7细胞表现出快速激活的钾电流,而注射KvLQT1异构体1加IsK cDNA的细胞则表现出缓慢激活的钾电流。注射KvLQT1异构体2质粒的细胞未检测到钾电流。注射异构体2/异构体1比例为1/1的细胞未检测到钾电流。注射比例为1/5和2/5的细胞表现出幅度明显降低的钾电流。IsK调节蛋白的共表达持续降低了异构体2的显性负效应。我们的结果表明,KvLQT1异构体2对异构体1通道具有明显的负显性作用,并且心脏KvLQT1钾通道复合物至少由三种不同的蛋白质组成,即:异构体1、异构体2和IsK。